Ratings by JPMorgan (Robert Marcus)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2026 | Insulet Corporation | PODD | Downgrade | Neutral (Overweight) |
166.82 (148.16) |
-11.19% | Details | |
| 5/7/2026 | Insulet Corporation | PODD | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/19/2026 | Insulet Corporation | PODD | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/10/2026 | Becton Dickinson | BDX | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/18/2025 | Penumbra | PEN | Upgrade | Overweight (Neutral) |
308.10 (325.18) |
5.54% | Details | |
| 11/6/2025 | Penumbra | PEN | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/8/2025 | Insulet Corporation | PODD | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/8/2025 | Becton Dickinson | BDX | Maintain | Neutral (Neutral) |
|
Details | ||
| 7/30/2025 | Penumbra | PEN | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/2/2025 | Becton Dickinson | BDX | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/19/2025 | Penumbra | PEN | Maintain | Neutral (Neutral) |
|
Details | ||
| 12/12/2024 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2024 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2024 | Becton Dickinson | BDX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/7/2024 | Nevro Corp | NVRO | Downgrade | Underweight (Neutral) |
8.54 (5.84) |
-31.62% | Details | |
| 2/23/2024 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2024 | Penumbra | PEN | Downgrade | Neutral (Overweight) |
258.30 (308.10) |
19.28% | Details | |
| 2/22/2024 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 12/20/2023 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2023 | Becton Dickinson | BDX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2023 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2023 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2023 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 10/17/2023 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2023 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2023 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 6/28/2023 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2023 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2023 | Becton Dickinson | BDX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/3/2023 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2023 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/1/2023 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2022 | Becton Dickinson | BDX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/4/2022 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2022 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2022 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2022 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2022 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2021 | Becton Dickinson | BDX | Downgrade | Neutral (Overweight) |
254.74 (192.00) |
-24.63% | Details | |
| 8/5/2021 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 2/27/2020 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 12/20/2019 | Nevro Corp | NVRO | Maintain | Neutral (N/A) |
|
Details | ||
| 12/20/2019 | Insulet Corporation | PODD | Maintain | Overweight (N/A) |
|
Details | ||
| 12/4/2019 | Penumbra | PEN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2019 | Insulet Corporation | PODD | Upgrade | Overweight (Neutral) |
120.89 (166.82) |
37.99% | Details | |
| 5/30/2019 | Penumbra | PEN | Upgrade | Overweight (Neutral) |
137.85 (325.18) |
135.89% | Details | |
| 11/6/2018 | Nevro Corp | NVRO | Downgrade | Neutral (Overweight) |
47.69 (8.54) |
-82.09% | Details |
